Renaissance Technologies’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,470
Closed -$29.1K 3625
2024
Q2
$29.1K Sell
4,470
-10
-0.2% -$70 ﹤0.01% 3346
2024
Q1
$34K Hold
4,480
﹤0.01% 3539
2023
Q4
$38K Sell
4,480
-60
-1% -$377 ﹤0.01% 3499
2023
Q3
$27K Hold
4,540
﹤0.01% 3491
2023
Q2
$49K Sell
4,540
-7,279
-62% -$49.2K ﹤0.01% 3620
2023
Q1
$74K Buy
11,819
+2,849
+32% +$21.2K ﹤0.01% 3577
2022
Q4
$63K Sell
8,970
-422
-4% -$2.98K ﹤0.01% 3747
2022
Q3
$78K Sell
9,392
-16,468
-64% -$159K ﹤0.01% 3660
2022
Q2
$199K Sell
25,860
-20,048
-44% -$196K ﹤0.01% 3652
2022
Q1
$597K Buy
45,908
+15,671
+52% +$211K ﹤0.01% 3073
2021
Q4
$496K Buy
30,237
+3,717
+14% +$84.3K ﹤0.01% 3078
2021
Q3
$700K Buy
26,520
+16,940
+177% +$494K ﹤0.01% 2736
2021
Q2
$328K Buy
+9,580
New +$375K ﹤0.01% 3117
2020
Q4
Sell
-2,540
Closed -$101K 3469
2020
Q3
$101K Buy
+2,540
New +$45.3K ﹤0.01% 3214

Other funds holding EVGN

Renaissance Technologies's EVGN Position: Q3 2024 in Review

Renaissance Technologies sold out of Evogene (EVGN) in Q3 2024, closing a stake of 4,470 shares — an estimated $29.1K sold.

Renaissance Technologies first reported a position in EVGN in Q3 2020 and held it in 14 quarters. The position peaked at $700K in Q3 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Renaissance Technologies reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 4,470 Evogene shares in Q3 2024, an estimated $29.1K.
  • Renaissance Technologies first reported a position in Evogene in Q3 2020 and held it in 14 quarters.
  • Renaissance Technologies's Evogene position peaked at $700K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.